GPs are being warned they can no longer prescribe a modified-release form of salbutamol, because of problems in the drug supply chain. Chiesi Limited said it could no longer supply pharmacies with the ...
The Department of Pharmaceuticals (DoP) has rejected a review application of Abbott Healthcare filed against National Pharmaceutical Pricing Authority (NPPA) on fixation of ceiling price for modified ...
SCOTTSDALE, Ariz., March 24, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and ...
SEATTLE, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and ...
AMSTERDAM, Nov. 25, 2015 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the European Commission (EC) has granted marketing authorization for NUMIENT (Levodopa and ...
Glucocorticoids have good efficacy as anti-inflammatory agents but are associated with adverse effects. Buttgereit et al. have compared the efficacy of modified-release prednisone with that of ...
he NICE-Wide Prioritisation Board met on 15 September 2025 and concluded that an evaluation would not be appropriate for this product. The 2024 voluntary scheme for branded medicines, pricing, access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback